Information about in vitro diagnostics included in News is intended for disclosure of corporate information. It is not intended to promote or advertise in vitro diagnostics.
Year
- Jul 14, 2025 News Release Notice Regarding Withdrawal of Application for Change of Market Classification
- Jun 26, 2025 News Release Notice regarding Selection of Our Company’s Shares as Loan Margin Trading Issue
- May 09, 2025 News Release (Update on Disclosed Matters) Notice regarding Application for Change of Market Classification to the Prime Market of the Tokyo Stock Exchange
- Apr 28, 2025 News Release TAUNS Laboratories, Inc. has Concluded a Capital and Business Alliance Agreement with Craif Inc., a Startup Developing Urinary MicroRNA-Based Tests for Early Cancer Detection.
- Apr 04, 2025 News Release Notice of Capital and Business Alliance with Aillis, Inc.and Acquisition of Shares through Third-Party Allocation of New Shares.
- Apr 01, 2025 News Release TAUNS Laboratories, Inc. has Concluded a Capital and Business Alliance Agreement with KINS Co., Ltd., a Healthcare Startup Specializing in Microbiomes.
- Feb 06, 2025 News Release Notice of Strategic Business Alliance with ZACROS Corporation
- Jan 28, 2025 News Release Patent on Method and Reagent for Detecting Target Substance Granted in Japan
- Jan 22, 2025 News Release (Update on Disclosed Matters) Notice of Entry into Master Transaction Agreement with Roche Diagnostics K.K.
- Dec 25, 2024 News Release Notice concerning Memorandum of Understanding to enter into Master Transaction Agreement between TAUNS Laboratories, Inc. and Roche Diagnostics K.K.
- Jul 14, 2025 News Release Notice Regarding Withdrawal of Application for Change of Market Classification
- Jun 26, 2025 News Release Notice regarding Selection of Our Company’s Shares as Loan Margin Trading Issue
- May 09, 2025 News Release (Update on Disclosed Matters) Notice regarding Application for Change of Market Classification to the Prime Market of the Tokyo Stock Exchange
- Apr 28, 2025 News Release TAUNS Laboratories, Inc. has Concluded a Capital and Business Alliance Agreement with Craif Inc., a Startup Developing Urinary MicroRNA-Based Tests for Early Cancer Detection.
- Apr 04, 2025 News Release Notice of Capital and Business Alliance with Aillis, Inc.and Acquisition of Shares through Third-Party Allocation of New Shares.
- Apr 01, 2025 News Release TAUNS Laboratories, Inc. has Concluded a Capital and Business Alliance Agreement with KINS Co., Ltd., a Healthcare Startup Specializing in Microbiomes.
- Feb 06, 2025 News Release Notice of Strategic Business Alliance with ZACROS Corporation
- Jan 28, 2025 News Release Patent on Method and Reagent for Detecting Target Substance Granted in Japan
- Jan 22, 2025 News Release (Update on Disclosed Matters) Notice of Entry into Master Transaction Agreement with Roche Diagnostics K.K.
- Dec 25, 2024 News Release Notice concerning Memorandum of Understanding to enter into Master Transaction Agreement between TAUNS Laboratories, Inc. and Roche Diagnostics K.K.
- Sep 01, 2021 Notice Announcement of Website Renewal
- Nov 18, 2019 Notice 2019/11/18-21 Exhibit at MEDICA 2019
- Nov 12, 2018 Notice 2018/11/12-15 Exhibit at MEDICA 2018
- Jul 31, 2018 Notice 2018/7/31-8/2 Exhibit at 70th AACC
- Nov 13, 2017 Notice 2017/11/13-16 Exhibit at MEDICA 2017
- Nov 14, 2016 Notice 2016/11/14-17 Exhibit at MEDICA 2016
- Jul 31, 2016 Notice 2016/7/31-8/4 Exhibited at 68th AACC
- Nov 16, 2015 Notice 2015/11/16-19 Exhibit at MEDICA 2015
- Nov 12, 2014 Notice 2014/11/12-15 Exhibit at MEDICA 2014
- Dec 06, 2010 Notice Product information website is opened.
